Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.86B 6,012B | Sales 2025 * | 16.35B 6,195B | Capitalization | 15.01B 5,688B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 583B | Net income 2025 * | 1.44B 546B | EV / Sales 2024 * | 1.87 x |
Net Debt 2024 * | 14.62B 5,542B | Net Debt 2025 * | 12.12B 4,593B | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
9.91
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 60 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+25.76% | 653B | |
+26.47% | 556B | |
-6.65% | 354B | |
+20.09% | 331B | |
+4.22% | 296B | |
+12.87% | 233B | |
+5.51% | 201B | |
-9.53% | 193B | |
-6.31% | 144B |